Symptomatic prognosis in patients with idiopathic hypertrophic subaortic stenosis (IHSS).
D000284:Administration, Oral; D000293:Adolescent; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy* / Q000473:pathology; D004417:Dyspnea / Q000188:drug therapy; D005500:Follow-Up Studies; D006352:Heart Ventricles / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008875:Middle Aged; D005996:Nitroglycerin / Q000008:administration & dosage; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage* / Q000627:therapeutic use; D011446:Prospective Studies; D013575:Syncope
D011433:Propranolol; D005996:Nitroglycerin; D007545:Isoproterenol